Selection Criteria for Lung-Cancer ScreeningMartin C. Tammemägi, Christine D. Berg, Hormuzd A. Katki et al.|New England Journal of Medicine|2013Cited by 1k
Targeting of Low-Dose CT Screening According to the Risk of Lung-Cancer DeathStephanie Kovalchik, Hormuzd A. Katki, Martin C. Tammemägi et al.|New England Journal of Medicine|2013Cited by 573
Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolitesMarguerite A. Butler, Fred F. Kadlubar, Nicholas P. Lang et al.|Pharmacogenetics|1992Cited by 418
Cancer Survivorship—Genetic Susceptibility and Second Primary Cancers: Research Strategies and RecommendationsLois B. Travis, Mark H. Greene, Charles S. Rabkin et al.|JNCI Journal of the National Cancer Institute|2006Cited by 344
Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogensPaolo Vineis, Steven R. Tannenbaum, Helmut Bartsch et al.|Nature|1994Cited by 275